A citation-based method for searching scientific literature

Anna Valeria Samarelli, Roberto Tonelli, Alessandro Marchioni, Giulia Bruzzi, Filippo Gozzi, Dario Andrisani, Ivana Castaniere, Linda Manicardi, Antonio Moretti, Luca Tabbì, Stefania Cerri, Bianca Beghè, Massimo Dominici, Enrico Clini. Int J Mol Sci 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Remodelling the extracellular matrix in development and disease.
Caroline Bonnans, Jonathan Chou, Zena Werb. Nat Rev Mol Cell Biol 2014
50

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
985
50

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
Keiko Hisatomi, Hiroshi Mukae, Noriho Sakamoto, Yuji Ishimatsu, Tomoyuki Kakugawa, Shintaro Hara, Hanako Fujita, Seiko Nakamichi, Hisashi Oku, Yoshishige Urata,[...]. BMC Pulm Med 2012
86
50

Follow-up chest radiographic findings in patients with MERS-CoV after recovery.
Karuna M Das, Edward Y Lee, Rajvir Singh, Mushira A Enani, Khalid Al Dossari, Klaus Van Gorkom, Sven G Larsson, Ruth D Langer. Indian J Radiol Imaging 2017
147
50

Eukaryotic mechanosensitive channels.
Jóhanna Arnadóttir, Martin Chalfie. Annu Rev Biophys 2010
234
50

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.
Ruirong Yuan, Andrea Kay, William J Berg, David Lebwohl. J Hematol Oncol 2009
174
50

Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study.
Dragana Jovanovic, Marina Roksandic Milenkovic, Jelena Kotur Stevuljevic, Jelena Markovic, Vesna Ceriman, Milica Kontic, Vesna Skodric Trifunovic. J Thorac Dis 2018
19
50

TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.
Laia Caja, Francesco Dituri, Serena Mancarella, Daniel Caballero-Diaz, Aristidis Moustakas, Gianluigi Giannelli, Isabel Fabregat. Int J Mol Sci 2018
111
50

Fibroblast pathology in inflammatory diseases.
Kevin Wei, Hung N Nguyen, Michael B Brenner. J Clin Invest 2021
1
100

Correction: Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study.
Peixun Zhang, Jia Li, Huixin Liu, Na Han, Jiabao Ju, Yuhui Kou, Lei Chen, Mengxi Jiang, Feng Pan, Yali Zheng,[...]. Bone Res 2020
62
50


Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.
Joseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, Coline H M van Moorsel, Hendrik W van Es, Frouke T van Beek, Marjolijn H L Struik, Maria Kokosi, Ryoko Egashira, Anne Laure Brun,[...]. Am J Respir Crit Care Med 2018
69
50

Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial.
Toby M Maher, Susanne Stowasser, Yasuhiko Nishioka, Eric S White, Vincent Cottin, Imre Noth, Moisés Selman, Zuzana Blahova, Daniel Wachtlin, Claudia Diefenbach,[...]. BMJ Open Respir Res 2018
13
50

Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.
H Takahashi, T Fujishima, H Koba, S Murakami, K Kurokawa, Y Shibuya, M Shiratori, Y Kuroki, S Abe. Am J Respir Crit Care Med 2000
203
50

Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
Ekaterina Krauss, Godja Gehrken, Fotios Drakopanagiotakis, Silke Tello, Ruth C Dartsch, Olga Maurer, Anita Windhorst, Daniel von der Beck, Matthias Griese, Werner Seeger,[...]. BMC Pulm Med 2019
9
50

Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
Brian D Hobbs, Rachel K Putman, Tetsuro Araki, Mizuki Nishino, Gunnar Gudmundsson, Vilmundur Gudnason, Gudny Eiriksdottir, Nuno Rodrigues Zilhao Nogueira, Josée Dupuis, Hanfei Xu,[...]. Am J Respir Crit Care Med 2019
31
50

Extended carrier lifetimes and diffusion in hybrid perovskites revealed by Hall effect and photoconductivity measurements.
Y Chen, H T Yi, X Wu, R Haroldson, Y N Gartstein, Y I Rodionov, K S Tikhonov, A Zakhidov, X-Y Zhu, V Podzorov. Nat Commun 2016
91
50

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.
Xiaoping Wu, Grace H Kim, Margaret L Salisbury, David Barber, Brian J Bartholmai, Kevin K Brown, Craig S Conoscenti, Jan De Backer, Kevin R Flaherty, James F Gruden,[...]. Am J Respir Crit Care Med 2019
46
50

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis.
Hideki Amano, Yoshio Matsui, Ko Hatanaka, Kanako Hosono, Yoshiya Ito. Inflamm Regen 2021
1
100


Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
348
50


Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
Richard J Allen, Beatriz Guillen-Guio, Justin M Oldham, Shwu-Fan Ma, Amy Dressen, Megan L Paynton, Luke M Kraven, Ma'en Obeidat, Xuan Li, Michael Ng,[...]. Am J Respir Crit Care Med 2020
63
50

Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.
Fei Liu, Justin D Mih, Barry S Shea, Alvin T Kho, Asma S Sharif, Andrew M Tager, Daniel J Tschumperlin. J Cell Biol 2010
437
50

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Hisashi Oku, Toshikatsu Shimizu, Tomoji Kawabata, Morio Nagira, Ichiro Hikita, Azumi Ueyama, Shuuichi Matsushima, Mikinori Torii, Akinori Arimura. Eur J Pharmacol 2008
265
50

Matrix crosslinking forces tumor progression by enhancing integrin signaling.
Kandice R Levental, Hongmei Yu, Laura Kass, Johnathon N Lakins, Mikala Egeblad, Janine T Erler, Sheri F T Fong, Katalin Csiszar, Amato Giaccia, Wolfgang Weninger,[...]. Cell 2009
50

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.
T E King, J A Tooze, M I Schwarz, K R Brown, R M Cherniack. Am J Respir Crit Care Med 2001
596
50


MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Ivan O Rosas, Thomas J Richards, Kazuhisa Konishi, Yingze Zhang, Kevin Gibson, Anna E Lokshin, Kathleen O Lindell, Jose Cisneros, Sandra D Macdonald, Annie Pardo,[...]. PLoS Med 2008
345
50

Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment.
Stefania Cerri, Matteo Monari, Aldo Guerrieri, Pierluigi Donatelli, Ilaria Bassi, Martina Garuti, Fabrizio Luppi, Sara Betti, Gianpiero Bandelli, Marco Carpano,[...]. Respir Med 2019
11
50

C-proSP-B: A Possible Biomarker for Pulmonary Diseases?
Nicolas Kahn, Anne-Kathrin Rossler, Katrin Hornemann, Thomas Muley, Ekkehard Grünig, Werner Schmidt, Felix J F Herth, Michael Kreuter. Respiration 2018
7
50

Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review.
Priyanka Singh, Veerandra Kumar, Sonu Kumar Gupta, Gudia Kumari, Malkhey Verma. Med Oncol 2021
4
50


Role of the Hippo Pathway in Fibrosis and Cancer.
Cho-Long Kim, Sue-Hee Choi, Jung-Soon Mo. Cells 2019
34
50

ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.
Shennea Marriott, Rubin S Baskir, Christa Gaskill, Swapna Menon, Erica J Carrier, Janice Williams, Megha Talati, Karen Helm, Catherine E Alford, Jonathan A Kropski,[...]. Am J Physiol Cell Physiol 2014
55
50

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
Chaomin Wu, Xiaoyan Chen, Yanping Cai, Jia'an Xia, Xing Zhou, Sha Xu, Hanping Huang, Li Zhang, Xia Zhou, Chunling Du,[...]. JAMA Intern Med 2020
50



Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Brent W Kinder, Kevin K Brown, Francis X McCormack, Joachim H Ix, Alma Kervitsky, Marvin I Schwarz, Talmadge E King. Chest 2009
138
50

Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort.
Louise A Organ, Anne-Marie R Duggan, Eunice Oballa, Sarah C Taggart, Juliet K Simpson, Arthur R Kang'ombe, Rebecca Braybrooke, Philip L Molyneaux, Bernard North, Yakshitha Karkera,[...]. Respir Res 2019
32
50

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.
Linda L Humphrey, Mark Deffebach, Miranda Pappas, Christina Baumann, Kathryn Artis, Jennifer Priest Mitchell, Bernadette Zakher, Rongwei Fu, Christopher G Slatore. Ann Intern Med 2013
360
50

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series.
Miriana d'Alessandro, Laura Bergantini, Elena Torricelli, Paolo Cameli, Federico Lavorini, Maria Pieroni, Rosa Metella Refini, Piersante Sestini, Elena Bargagli. Cancers (Basel) 2021
5
50

Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Patsy S H Soon, Edward Kim, Cindy K Pon, Anthony J Gill, Katrina Moore, Andrew J Spillane, Diana E Benn, Robert C Baxter. Endocr Relat Cancer 2013
86
50

Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis.
Nikolaos G Frangogiannis. Curr Pathobiol Rep 2016
18
50

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Jürgen Behr, Antje Prasse, Michael Kreuter, Johannes Johow, Klaus F Rabe, Francesco Bonella, Reiner Bonnet, Christian Grohe, Matthias Held, Heinrike Wilkens,[...]. Lancet Respir Med 2021
27
50

COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Luciano Gattinoni, Davide Chiumello, Pietro Caironi, Mattia Busana, Federica Romitti, Luca Brazzi, Luigi Camporota. Intensive Care Med 2020
773
50

Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis.
Masaru Ando, Eishi Miyazaki, Takeo Ito, Shigeo Hiroshige, Shin-ich Nureki, Takuya Ueno, Ryuichi Takenaka, Tetsujiro Fukami, Toshihide Kumamoto. Lung 2010
49
50

Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
Roland M du Bois, Derek Weycker, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Alex Kartashov, Talmadge E King, Lisa Lancaster, Paul W Noble, Steven A Sahn,[...]. Am J Respir Crit Care Med 2011
285
50

Feeling the hidden mechanical forces in lipid bilayer is an original sense.
Andriy Anishkin, Stephen H Loukin, Jinfeng Teng, Ching Kung. Proc Natl Acad Sci U S A 2014
149
50

Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.
Marco Chilosi, Venerino Poletti, Alberto Zamò, Maurizio Lestani, Licia Montagna, Paola Piccoli, Serena Pedron, Manuela Bertaso, Aldo Scarpa, Bruno Murer,[...]. Am J Pathol 2003
498
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.